Suekane Shigetaka | 久留米大学 医学部泌尿器科
スポンサーリンク
概要
関連著者
-
SUEKANE Shigetaka
Department of Urology, Kurume University School of Medicine
-
Noguchi M
Department Of Urology Kurume University School Of Medicine
-
Nishikori M
Department Of Urology Kurume University School Of Medicine
-
Suekane Shigetaka
Department Of Urology Kurume University School Of Medicine
-
Suekane Shigetaka
久留米大学 医学部泌尿器科
-
NOGUCHI Masanori
Department of Urology, Kurume University School of Medicine
-
Noguchi Masanori
Department Of Urology
-
Noguchi Masanori
Department of Health Promotion and Education, Osaka Medical Center for Health Science and Promotion
-
Nakao Masanobu
Department Of Immunology Kurume University School Of Medicine
-
NODA Shinshi
Department of Urology, Kurume University School of Medicine
-
Itoh K
Kurume Univ. School Of Medicine Fukuoka
-
Itoh K
Kurume Univ. School Of Medicine Fukuoka Jpn
-
Noda Shinshi
Department Of Urology Kurume University School Medicine
-
Noda Shinshi
Department Of Urology
-
Itoh K
Departments Of Immunology Kurume University School Of Medicine
-
Itoh Kyogo
Departments Of Immunology ; Departments Of Cancer Vaccine Division Of Kurume University Research Cen
-
Itoh Kyogo
Cancer Vaccine Development Division Research Center For Innovative Cancer Therapy Kurume University
-
Nakamura Masakazu
Department Of Health Promotion And Education Osaka Medical Center For Health Science And Promotion
-
Nakagawa Masayuki
Department Of Urology Kagoshima University Hospital
-
YAMADA Akira
Cancer Vaccine Development Division, Kurume University Research Center for Innovative Cancer Therapy
-
Yamada Akira
久留米大学 医学部泌尿器科
-
Yamada A
Cancer Vaccine Development Division Kurume University Research Center For Innovative Cancer Therapy
-
Yamada Akira
Kurume University Research Center For Innovative Cancer Therapy Kurume University School Of Medicine
-
Itoh Kyogo
久留米大学 医学部免疫学
-
Yao Akihisa
Cancer Vaccine Development Division Research Center For Innovative Cancer Therapy And Center Of The
-
Itoh K
Department Of Immunology Kurume University School Of Medicine
-
Itoh Kyogo
Department Of Lmmunology Kurume University School Of Medicine
-
ITOH Kyogo
Departments of Immunology, Kurume University School of Medicine
-
Itoh Kyogo
Department Of Immunology
-
MATSUOKA Kei
Department of Urology, Kurume University School of Medicine
-
Yamada A
Department Of Immunology Kurume University School Of Medicine
-
Matsuoka Kei
Department Of Urology Kurume University School Of Medicine
-
Matsuoka Kei
Department Of Geosystem Engineering The University Of Tokyo
-
Yamada Akira
Department Of Immunology Kurume University School Of Medicine
-
Yamada Akira
Cancer Vaccine Development Division Kurume University Research Center For Innovative Cancer Therapy
-
YAMADA Akira
Departments of Immunology, Kurume University School of Medicine
-
Namiki Mikio
Department Of Integrative Cancer Therapy And Urology Kanazawa University Graduate School Of Medical
-
ITOH Kyogo
Cancer Vaccine Development Division, Kurume University Research Center for Innovative Cancer Therapy
-
Yamada Akira
Department Of Cardiology Aso-iizuka Hospital
-
Suetsugu Norie
久留米大学 医学部泌尿器科学
-
Suetsugu Norie
Department Of Immunology Kurume University School Of Medicine
-
YAO Akihisa
Department of Immunology, Kurume University School of Medicine
-
KATAGIRI Kazuko
Department of Immunology, Kurume University School of Medicine
-
YAMANA Hideaki
Department of Surgery, Kurume University School of Medicine
-
Itoh Kyogo
近畿大学 医学部泌尿器科学
-
Kawamura Koji
Department Of Urology Graduate School Of Medicine Chiba University
-
Kojiro Masamichi
Department Of Gastroenterology And Hepatology Kinki University School Of Medicine
-
KOMATSU Nobukazu
Department of Immunology, Kurume University School of Medicine
-
Kunimi Kazuto
Department Of Urology Fukui Red Cross Hospital
-
Itoh Kyogo
Division Of Cancer Vaccine Development At The Research Center For Innovative Cancer Therapy Kurume U
-
NAKAO Masanobu
Department of Immunology, Kurume University School of Medicine
-
INOUE Michiro
Department of Urology, Kurume University School of Medicine
-
NISHITANI Masaaki
Department of Urology, Tokushima University Graduate School of Medicine
-
KOMOHARA Yoshihiro
Department of Immunology, Kurume University School of Medicine
-
KOKUBU Takako
Department of Immunology, Kurume University School of Medicine
-
NAITOH Masayasu
Department of Immunology, Kurume University School of Medicine
-
HONMA Shigenori
Department of Surgery, Hokkaido University Graduate School of Medicine
-
KANAYAMA Hiroomi
Department of Urology, Tokushima University Graduate School of Medicine
-
MIYAJIMA Jiro
Departments of Urology,and Immunology,Kurume University School of Medicine
-
NAKASHIMA OSAMU
Department of Pathology and Research Center of Innovative Cancer Therapy of the 21st Century COE Pro
-
Itoh Kyogo
Cancer Vaccine Development Division Kurume University Research Center For Innovative Cancer Therapy
-
Yamana H
Department Of Surgery Kurume University School Of Medicine
-
Yamana Hideaki
Department Of Surgery Kurume University School Of Medicine
-
Nakao Masanobu
Department Of Immunology
-
Kokubu Takako
Department Of Immunology Kurume University School Of Medicine
-
Honma Shigenori
Department Of Surgery Hokkaido University Graduate School Of Medicine
-
Naitoh Masayasu
Department Of Immunology Kurume University School Of Medicine
-
Namiki Mikio
Department Of Integrated Cancer Therapy And Urology Kanazawa University Graduate School
-
Miyajima Jiro
Departments Of Urology And Immunology Kurume University School Of Medicine
-
Miyajima Jiro
Department Of Urology Kurume University School Of Medicine
-
Kanayama Hiroomi
Department Of Urology The University Of Tokushima School Of Medicine
-
Kanayama Hiroomi
Department Of Urology Tokushima University Graduate School Of Medicine
-
Nishitani Masaaki
Department Of Urology The University Of Tokushima School Of Medicine
-
Komohara Yoshihiro
Cancer Vaccine Development Division Kurume University Research Center For Innovative Cancer Therapy
-
Komatsu Kazuto
Department Of Urology Fukui Red Cross Hospital
-
ICHIKI Junji
Department of Urology,Kurume University School of Medicine
-
Ichiki Junji
Department Of Urology Kurume University School Of Medicine
-
Yamada Satoko
Department Of Urology Kurume University School Of Medicine
-
SHIMADA AKIHIKO
Department of Urology, Kurume University School of Medicine
-
Komohara Yoshihiro
Department Of Cell Pathology Graduate School Of Medical Sciences Kumamoto University
-
Hiraoka Masahiro
Therapeutic Radiology And Oncology Kyoto University Graduate School Of Medicine
-
YAHARA JYUNRO
Department of Urology, Kurume University School of Medicine
-
Noguchi Masanori
Department Of Urology Kurume University School Of Medicine
-
Kameyama Kaori
Department Of Pathology Keio University School Of Medicine
-
Komatsu Nobukazu
Department Of Immunology Kurume University School Of Medicine
-
Komatsu Nobukazu
Department Of Immunology And Immunotherapy Kurume University School Of Medicine
-
Yahara Jyunro
Department Of Urology Kurume University School Of Medicine
-
Shimada Akihiko
Department Of Surgery Keiyu Hospital
-
Kakehi Yoshiyuki
Department Of Urology Kagawa University Graduate School Of Medicine
-
Katagiri Kazuko
Departments Of Immunology Kurume University School Of Medicine
-
Inoue Michiro
Department Of Urology Kurume University School Of Medicine
-
ISEKI Kanako
Cancer Vaccine Development Division, Kurume University Research Center for Innovative Cancer Therapy
-
MATSUNAGA Hiromi
Department of Immunology and Immunotherapy, Kurume University School of Medicine
-
Namiki Mikio
Department Of Integrative Cancer Therapy And Urology Kanazawa University Graduate School Of Medical
-
Iseki Kanako
Cancer Vaccine Development Division Kurume University Research Center For Innovative Cancer Therapy
-
Murasugi Hiroko
Department Of Pediatrics Tokyo Women's Medical University School Of Medicine
-
Naoi Makito
Department Of Urology Toho University Sakura Medical Center
-
Matsunaga Hiromi
Department Of Immunology And Immunotherapy Kurume University School Of Medicine
著作論文
- Phase I trial of patient-oriented vaccination in HLA-A2-positive patients with metastatic hormone-refractory prostate cancer
- Histocompatibility Leukocyte Antigen-A2-restricted and Tumor-specific Cytotoxic T Lymphocytes from Tumor-infiltrating Lymphocytes of a Patient with Testicular Embryonal Cancer
- Phase I trial of personalized peptide vaccination for cytokine-refractory metastatic renal cell carcinoma patients
- Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy
- Treatment of Bilateral Staghorn Calculi by Endourology and Extracorporeal Shockwave Lithotripsy : Report of 4 Cases
- Early catheter removal 3 days after radical retropubic prostatectomy
- Evaluation of a new oil adjuvant for use in peptide-based cancer vaccination